5WUV
Crystal structure of Certolizumab Fab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PAL/PLS BEAMLINE 5C (4A) |
Synchrotron site | PAL/PLS |
Beamline | 5C (4A) |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-04-08 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 1.00 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 58.330, 63.696, 161.415 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 29.165 - 1.952 |
R-factor | 0.1492 |
Rwork | 0.148 |
R-free | 0.17870 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.007 |
RMSD bond angle | 1.060 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX (1.9_1692) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 37.960 |
High resolution limit [Å] | 1.950 |
Number of reflections | 43749 |
<I/σ(I)> | 28.2 |
Completeness [%] | 98.2 |
Redundancy | 5.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.1M bis-Tris pH5.5, 0.2M Ammunium sulfate, 25% PEG3350 |